Log in

goodpods headphones icon

To access all our features

Open the Goodpods app
Close icon
Bloomberg Businessweek - The Outlook for COVID-19 Treatments

The Outlook for COVID-19 Treatments

06/19/20 • 40 min

Bloomberg Businessweek

Dr. Ian Lustbader, Clinical Professor of Medicine at NYU, discusses the latest on Dexamethasone as a treatment for COVID-19 and New York City’s phase two of reopening. Bloomberg Businessweek Editor Joel Weber and Businessweek Editor Silvia Killingsworth walk through stories from the food section in this week's magazine. We get Businessweek Economics with Bloomberg News Economics Reporter Steve Matthews. He talks about his interview with Atlanta Fed President Raphael Bostic. Jason Kelly, CEO at Ginkgo Bioworks, walks through enabling large-scale COVID-19 testing. And we Drive to the Close with Kevin Miller, CIO of E-Valuator Funds.

Hosts: Carol Massar and Jason Kelly. Producer: Doni Holloway.

See omnystudio.com/listener for privacy information.

plus icon
bookmark

Dr. Ian Lustbader, Clinical Professor of Medicine at NYU, discusses the latest on Dexamethasone as a treatment for COVID-19 and New York City’s phase two of reopening. Bloomberg Businessweek Editor Joel Weber and Businessweek Editor Silvia Killingsworth walk through stories from the food section in this week's magazine. We get Businessweek Economics with Bloomberg News Economics Reporter Steve Matthews. He talks about his interview with Atlanta Fed President Raphael Bostic. Jason Kelly, CEO at Ginkgo Bioworks, walks through enabling large-scale COVID-19 testing. And we Drive to the Close with Kevin Miller, CIO of E-Valuator Funds.

Hosts: Carol Massar and Jason Kelly. Producer: Doni Holloway.

See omnystudio.com/listener for privacy information.

Previous Episode

undefined - Businessweek Extra - Paul Reiser

Businessweek Extra - Paul Reiser

Hosted by Carol Massar and Jason Kelly.

Featuring a conversation with comedian Paul Reiser, on how Hollywood can bounce back post coronavirus.

See omnystudio.com/listener for privacy information.

Next Episode

undefined - The Case for Quotas

The Case for Quotas

Bloomberg News Diversity and Sustainability Reporter Rebecca Greenfield writes: "They’ve helped women. Why not apply them to the boardrooms and middle management of the Fortune 500?" Hear the full cover story.

Hosts: Carol Massar and Jason Kelly. Producer: Doni Holloway.

See omnystudio.com/listener for privacy information.

Episode Comments

Generate a badge

Get a badge for your website that links back to this episode

Select type & size
Open dropdown icon
share badge image

<a href="https://goodpods.com/podcasts/bloomberg-businessweek-70931/the-outlook-for-covid-19-treatments-3759834"> <img src="https://storage.googleapis.com/goodpods-images-bucket/badges/generic-badge-1.svg" alt="listen to the outlook for covid-19 treatments on goodpods" style="width: 225px" /> </a>

Copy